Ro5-2904
Ro5-2904[1] (Triflunordazepam) is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]
See also
References
- ↑ DE Patent 1136709
- ↑ Archives Internationales de Pharmacodynamie et de Therapie. (1965). Vol 154, p 131.
- ↑ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.
|
---|
| 1,4-Benzodiazepines | |
---|
| 1,5-Benzodiazepines | |
---|
| 2,3-Benzodiazepines* | |
---|
| Triazolobenzodiazepines | |
---|
| Imidazobenzodiazepines | |
---|
| Oxazolobenzodiazepines | |
---|
| Thienodiazepines | |
---|
| Pyridodiazepines | |
---|
| Pyrazolodiazepines | |
---|
| Pyrrolodiazepines | |
---|
| Tetrahydroisoquinobenzodiazepines | |
---|
| Pyrrolobenzodiazepines* |
- Anthramycin
- Mazethramycin
- Porothramycin
- Sibiromycin
- Tomaymycin
|
---|
| Benzodiazepine prodrugs | |
---|
| |
|
|
---|
| Alcohols | |
---|
| Barbiturates | |
---|
| Benzodiazepines | |
---|
| Carbamates | |
---|
| Flavonoids | |
---|
| Imidazoles | |
---|
| Kavalactones |
- Kava
- Yangonin
- 10-methoxyyangonin
- 11-methoxyyangonin
- 11-hydroxyyangonin
- Desmethoxyyangonin
- 11-methoxy-12-hydroxydehydrokavain
- 7,8-dihydroyangonin
- Kavain
- 5-hydroxykavain
- 5,6-dihydroyangonin
- 7,8-dihydrokavain
- 5,6,7,8-tetrahydroyangonin
- 5,6-dehydromethysticin
- Methysticin
- 7,8-dihydromethysticin
|
---|
| Neuroactive steroids | |
---|
| Nonbenzodiazepines | |
---|
| Phenols | |
---|
| Piperidinediones | |
---|
| Pyrazolopyridines | |
---|
| Quinazolinones | |
---|
| Volatiles/gases | |
---|
| Others/unsorted |
- 3-Hydroxybutanal
- α-EMTBL
- AA-29504
- Avermectins (e.g., ivermectin)
- Bromide compounds (e.g., lithium bromide, potassium bromide, sodium bromide)
- Carbamazepine
- Chloralose
- Chlormezanone
- Clomethiazole
- DEABL
- Dihydroergolines (e.g., dihydroergocryptine, dihydroergosine, dihydroergotamine, ergoloid (dihydroergotoxine))
- DS2
- Efavirenz
- Etazepine
- Etifoxine
- Fenamates (e.g., flufenamic acid, mefenamic acid, niflumic acid, tolfenamic acid)
- Fluoxetine
- Flupirtine
- Hopantenic acid
- Lanthanum
- Lignans (e.g., 4-O-methylhonokiol, honokiol, magnolol, obovatol)
- Loreclezole
- Menthyl isovalerate (validolum)
- Monastrol
- Niacin
- Nicotinamide (niacinamide)
- Org 25,435
- Phenytoin
- Propanidid
- Retigabine (ezogabine)
- Safranal
- Seproxetine
- Stiripentol
- Sulfonylalkanes (e.g., sulfonmethane (sulfonal), tetronal, trional)
- Terpenoids (e.g., borneol)
- Topiramate
- Valerian constituents (e.g., isovaleric acid, valerenic acid, valerenol)
- Unsorted benzodiazepine site PAMs: MRK-409 (MK-0343)
- TCS-1105
- TCS-1205
|
---|
| See also: GABAergics |
|